GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Long-Term Debt

Concord Biotech (BOM:543960) Long-Term Debt : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Long-Term Debt?

Concord Biotech's Long-Term Debt for the quarter that ended in Mar. 2024 was ₹0 Mil.

Concord Biotech's quarterly Long-Term Debt declined from Mar. 2023 (₹62 Mil) to Sep. 2023 (₹0 Mil) but then stayed the same from Sep. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil).

Concord Biotech's annual Long-Term Debt declined from Mar. 2022 (₹312 Mil) to Mar. 2023 (₹62 Mil) and declined from Mar. 2023 (₹62 Mil) to Mar. 2024 (₹0 Mil).


Concord Biotech Long-Term Debt Historical Data

The historical data trend for Concord Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Long-Term Debt Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
355.28 562.50 312.48 62.36 -

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Long-Term Debt Get a 7-Day Free Trial 312.48 - 62.36 - -

Concord Biotech  (BOM:543960) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Concord Biotech Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Biotech (BOM:543960) Business Description

Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines